Asher Kornbluth, MD

New York, New York 10128

0 studies enrolling now · 4 studies all time

What they study most

Crohn's Disease

Studies at this site

• Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease — Completed
• Extension Study of Semapimod 60 mg IV x 3 Days — Completed
• Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo — Completed
• Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease — Completed